Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
2,426,389
-
Shares change
-
-289,464
-
Total reported value, excl. options
-
$105,360,785
-
Value change
-
-$12,416,925
-
Put/Call ratio
-
0%
-
Number of buys
-
30
-
Number of sells
-
-30
-
Price
-
$43.48
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2020
85 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q3 2020.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,426,389 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (504,872 shares), MORGAN STANLEY (414,383 shares), JPMORGAN CHASE & CO (327,399 shares), BANK OF AMERICA CORP /DE/ (188,178 shares), Wharton Business Group, LLC (112,675 shares), LPL Financial LLC (71,851 shares), WELLS FARGO & COMPANY/MN (69,780 shares), Hochman Cole Investment Advisors, Inc. (57,104 shares), HighTower Advisors, LLC (51,172 shares), and FIRST CITIZENS BANK & TRUST CO (49,665 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.